Wells Fargo’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.75M | Sell |
196,300
-2,059
| -1% | -$28.9K | ﹤0.01% | 2668 |
|
|
2025
Q1 | $3.1M | Buy |
198,359
+145,904
| +278% | +$2.28M | ﹤0.01% | 2477 |
|
|
2024
Q4 | $731K | Buy |
52,455
+16,682
| +47% | +$232K | ﹤0.01% | 3479 |
|
|
2024
Q3 | $333K | Sell |
35,773
-792
| -2% | -$7.37K | ﹤0.01% | 3884 |
|
|
2024
Q2 | $340K | Buy |
36,565
+8,807
| +32% | +$81.9K | ﹤0.01% | 3815 |
|
|
2024
Q1 | $275K | Buy |
27,758
+6,144
| +28% | +$60.9K | ﹤0.01% | 3914 |
|
|
2023
Q4 | $69.8K | Sell |
21,614
-65,164
| -75% | -$210K | ﹤0.01% | 4706 |
|
|
2023
Q3 | $461K | Sell |
86,778
-19,972
| -19% | -$106K | ﹤0.01% | 3564 |
|
|
2023
Q2 | $1.02M | Buy |
106,750
+44,115
| +70% | +$420K | ﹤0.01% | 3279 |
|
|
2023
Q1 | $689K | Buy |
62,635
+59,195
| +1,721% | +$651K | ﹤0.01% | 3401 |
|
|
2022
Q4 | $50.9K | Sell |
3,440
-422
| -11% | -$6.25K | ﹤0.01% | 4544 |
|
|
2022
Q3 | $73K | Buy |
3,862
+196
| +5% | +$3.71K | ﹤0.01% | 4465 |
|
|
2022
Q2 | $78K | Sell |
3,666
-135,069
| -97% | -$2.87M | ﹤0.01% | 4523 |
|
|
2022
Q1 | $2.67M | Sell |
138,735
-2,827
| -2% | -$54.4K | ﹤0.01% | 2855 |
|
|
2021
Q4 | $2.94M | Sell |
141,562
-631,652
| -82% | -$13.1M | ﹤0.01% | 2927 |
|
|
2021
Q3 | $18.5M | Sell |
773,214
-124,758
| -14% | -$2.98M | ﹤0.01% | 1665 |
|
|
2021
Q2 | $24.5M | Buy |
897,972
+21,388
| +2% | +$584K | 0.01% | 1496 |
|
|
2021
Q1 | $25.4M | Buy |
876,584
+233,128
| +36% | +$6.74M | 0.01% | 1439 |
|
|
2020
Q4 | $18.1M | Buy |
643,456
+87,093
| +16% | +$2.45M | ﹤0.01% | 1618 |
|
|
2020
Q3 | $16.3M | Buy |
556,363
+29,236
| +6% | +$857K | ﹤0.01% | 1533 |
|
|
2020
Q2 | $15.9M | Buy |
527,127
+113,356
| +27% | +$3.43M | ﹤0.01% | 1497 |
|
|
2020
Q1 | $12.3M | Buy |
+413,771
| New | +$12.3M | ﹤0.01% | 1518 |
|